Welsh Carson Anderson & Stowe

What Welsh Carson Anderson & Stowe does

Welsh, Carson, Anderson & Stowe (WCAS) is a U.S. private equity firm founded in 1979 that invests exclusively in two sectors: technology and healthcare. The firm partners with management teams to build value through operational improvements, growth initiatives, and strategic acquisitions, deploying capital across a series of private equity funds. Over 45+ years, WCAS has raised and managed 18 private equity funds totaling over $33 billion of committed capital, building a portfolio spanning more than 100 technology companies (with $12.5 billion of equity deployed across 13 funds) and approximately 90 healthcare companies (with roughly $10 billion of equity deployed).

WCAS's active portfolio spans both majority-controlled subsidiaries and minority positions across a diversified set of sub-sectors including fintech (EquiLend, Clearwater Analytics), government technology (GovCIO), supply chain connectivity (TrueCommerce), low-code development (Quickbase), learning management (Absorb Software), K-12 operations (LINQ), value-based care (Valtruis), dental benefits (LIBERTY Dental Plan), pharmaceutical compounding (Leiters), specialty pharmacy (Shields Health Solutions), diagnostic imaging (Lumexa Imaging), physician practice management (United Musculoskeletal Partners, Constitution Surgery Alliance), and the architecture/engineering/construction industry (AIA Contract Documents). The firm operates through dedicated Technology and Healthcare groups with sub-vertical specialization (FinTech, GovTech, EdTech, HCM, Payments, HCIT, Payor Services, Pharma Value Chain, Care Delivery) and maintains offices in New York and San Francisco. Notable operating partners include former CEOs of Mastercard (Gene Lockhart), GE Healthcare U.S./Canada (Lee Cooper), Baylor Scott & White Health (Jim Hinton), Yale Medicine (Dr. Paul Taheri), Ultimate Software (Julie Dodd), and former senior leaders of LinkedIn, Gartner, McKinsey, and Bain.

WCAS's revenue model is based on traditional private equity economics: management fees (typically 1.5–2% annually) charged on committed or invested fund capital plus carried interest on realized fund profits, governed by private limited partnership agreements with institutional investors. Distribution is restricted to qualified institutional and high-net-worth investors; the Connecticut Retirement Plans and Trust Funds is one named LP with up to a $300 million commitment to the current WCAS XV fund. WCAS does not publicly disclose revenue or financial statements. The firm exited several marquee investments in recent years, including Shields Health Solutions (sold to Walgreens Boots Alliance for ~$1.37 billion in 2022) and Green Street (majority sold to TA Associates in 2022), and is taking Select Medical Holdings private in a $3.9 billion all-cash deal announced March 2026.

Name

Welsh Carson Anderson & Stowe

Legal name

Welsh, Carson, Anderson & Stowe

Website

https://www.wcas.com/

Company type

Private

Founded year

1979

Operating status

Operating

Headcount range

51–100 employees

Short description

Welsh, Carson, Anderson & Stowe (WCAS) is a private equity firm founded in 1979 that invests exclusively in technology and healthcare, managing over $33 billion of committed capital across 18 funds and partnering with management teams to build category-leading companies.

Ownership category

akta.pro rank

Product category

Private Equity

NAICS

Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)

SIC

Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Institutional Capital Introduction (LP/Family Office/Endowment Matching) (FSAEALAI)

akta.pro secondary industry

Strategic Partnerships, Alliances & JVs Advisory (BPAHADAI)

Keywords

• Private equity investments
• Healthcare investments
• Technology investments
• Growth equity
• Buyout investing

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Distribution channels1 record

Marketing channels2 records

Core offering

Welsh, Carson, Anderson & Stowe (WCAS) is a private equity investment firm that raises and manages private equity funds dedicated to healthcare and technology investments. The firm partners with management teams to provide growth capital, support strategic acquisitions, and drive operational improvements in portfolio companies across both sectors, charging management fees and earning carried interest from limited partner investors.

Product overview

Welsh, Carson, Anderson & Stowe (WCAS) is a private equity firm that invests in healthcare and technology companies. Rather than offering its own products, WCAS acquires and supports portfolio companies across various sectors including healthcare services, healthcare IT, technology platforms, and financial technology. The firm's portfolio includes companies such as EquiLend (securities finance technology), GovCIO (federal government technology), Quickbase (low-code development), TrueCommerce (supply chain connectivity), Absorb (learning management), LINQ (K-12 operations technology), ImageTrend (public safety/healthcare software), and various healthcare delivery and services companies.

Differentiator

Problem solved

Functional benefit

Products and services

• WCAS Private Equity Funds

Quantifiable outcome

• Shields Health Solutions grew revenue at a compounded annual rate of over 50% during WCAS ownership, creating nearly 1,200 new jobs and adding 50 new health system partnerships.
• +2 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core.

• Amir Neshat (Founder, LIBERTY Dental Plan)coreStrategic or Co-development PartnerAmir Neshat founded LIBERTY Dental Plan and transitioned from CEO to Chairman of the Board following WCAS's majority investment. The founder-led partnership is a key element of WCAS's investment strategy.
• The American Institute of Architects (AIA)coreStrategic or Co-development PartnerThe American Institute of Architects partnered with WCAS and True Wind Capital in AIA Contract Documents. AIA, which has a 140-year legacy in the AEC industry, remains an investor and strategic partner following WCAS's majority investment. Over 40,000 architects, engineers, and contractors use ACD to draft and collaborate on over 1.5 million documents annually.
• Humana (CenterWell)coreStrategic or Co-development PartnerWCAS and Humana's CenterWell Senior Primary Care formed joint ventures to expand value-based primary care clinics for Medicare patients, deploying up to $1.2 billion in a second JV following an initial $800 million JV deploying 67 clinics.
• Resurgens OrthopaedicscoreStrategic or Co-development PartnerWCAS and Resurgens Orthopaedics (the largest orthopedic group in Georgia) formed a joint venture to build a national physician-owned orthopedic platform, with Resurgens serving as the founding partner and Alex Bateman as CEO.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Thoma Bravo: Large-scale U.S. private equity firm exclusively focused on software and technology companies, with a long-tenured sector-specialist model closely mirroring WCAS's technology investing approach (https://thomab Bravo.com).
• Vista Equity Partners: Tech-focused buyout firm investing in enterprise software companies with an operating-partner model. Directly comparable to WCAS's software and tech-enabled services portfolio (Quickbase, Clearwater, Absorb, TrueCommerce) (https://www.vistaequitypartners.com).
• New Mountain Capital: U.S. private equity firm investing in healthcare and technology-enabled business services, sharing WCAS's two-vertical concentration and sector-specialist orientation (https://www.newmountaincapital.com).
• Bain Capital Tech Opportunities: Growth and buyout franchise within Bain Capital focused on technology and tech-enabled services, overlapping with WCAS's enterprise software and fintech investing themes (https://www.baincapital.com).
• Warburg Pincus: Growth-oriented PE firm with deep healthcare and technology investing franchises, comparable to WCAS in size and sector focus, and a co-investor alongside WCAS in Clearwater Analytics (https://www.warburgpincus.com).
• Permira: Global PE firm specializing in technology, consumer, and financial services. Directly comparable in enterprise software and fintech investing themes and a co-investor with WCAS in Clearwater Analytics (https://www.permira.com).

Broad incumbents

• KKR: Global alternative asset manager with dedicated technology and healthcare verticals. Overlaps with WCAS in healthcare services, healthcare IT, and software but operates across a much broader sector mandate (https://www.kkr.com).
• TPG: Large global PE firm with dedicated healthcare and technology investing platforms (TPG Capital, TPG Growth). Comparable in healthcare delivery and software themes but with broader geographic and sector reach (https://www.tpg.com).
• Advent International: Global PE firm with active healthcare services, healthcare IT, and technology practices. Comparable to WCAS's two-vertical model with broader geographic diversification (https://www.adventinternational.com).
• EQT Private Equity: Global PE firm with dedicated healthcare and technology teams. Comparable to WCAS in healthcare services and enterprise software and an acquirer of WCAS's Avetta portfolio company (https://www.eqtgroup.com).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/welsh-carson-anderson-&-stowe

Revenue estimate

Valuation estimate

Number of profiles

Profiles37 records

Subsidiaries21 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A30 records

Investments33 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Welsh Carson Anderson & Stowe